Elecsys Anti-SARS-CoV-2 antibody test is available at more than 20 commercial and hospital lab sites across the US. Credit: Fernando Zhiminaicela / Pixabay.

Roche has introduced the Elecsys Anti-SARS-CoV-2 Covid-19 antibody test at more than 20 commercial and hospital lab sites across the US.

The company has partnered with LabCorp to make the test available at the laboratories.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Now, Roche plans to make the Covid-19 antibody test available in more than 200 sites over the next few weeks, a step that will help the laboratories to conduct approximately two million tests per week.

The US Food and Drug Administration (FDA) awarded Emergency Use Authorisation for Roche’s Elecsys Anti-SARS-CoV-2 antibody test earlier this month.

Roche Diagnostics North America president and CEO Matt Sause said: “Roche is proud to make this highly accurate serology test available in the US to determine if a person has developed antibodies to Covid-19.

“Reliable, high-quality antibody testing is essential to help us overcome this pandemic and will play an important role in getting people back to work.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The antibody test is designed to detect mature (high-affinity) antibodies that developed late in the immune response. The process has a specificity of 99.8% based on the measurement of 5,272 samples and reduces false-positive results.

LabCorp president and chief medical officer Dr Brian Caveney said: “Our long-standing relationship and collaboration with Roche enables us to introduce many innovative, high-quality tests for clinicians and patients, which is more important now than ever before.

“Roche’s new antibody test allows LabCorp to provide more options and increase Covid-19 testing capacity as we support the country’s response to the health crisis.”

Coronavirus (Covid-19) has infected more than 1.5 million people in the US. The death toll in the country has reached 91,000.